Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as ...

The testimony of Srimanikandan Ramamoorthy, dubbed the essential witness by the US Department of Justice, is critical, ...

A US court has requested Cognizant to specify the nature of its trade secrets after Infosys denied the theft allegations, ...

Cognizant sued Infosys, accusing it of stealing secrets related to its US subsidiary TriZetto's healthcare insurance software ...

Members of the Alphabet Workers Union had challenged the National Labor Relations Board's decision to only order Google to ...

A new AI development framework and services are said to fast track multi-agent adoption by enabling interoperability and scalability to transform business processes.

Cognizant released a study on young consumers’ increased use of AI, and discussed how that will impact designing AI systems ...

On the counterclaim filed by Infosys in the TriZetto trade secrets case, Kumar says he is protecting the intellectual ...

Joint study between Cognizant and Oxford Economics predicts AI will drive 46% of consumer transactions in the U.S. by 2030, underscoring the business need to leverage AI to reimagine customer ...

Get the latest updates on the company's financial performance, strategic acquisitions, and market shifts. Explore detailed ...